API manufacturers targeted by China’s new anti-monopoly bureau
Minhua Chu · 11/24/2021
Shortly after the government of China launched its anti-monopoly bureau, an active pharmaceutical ingredient (API) manufacturer from Nanjing was fined RMB6.58 million ($1 million) for abusing its dominant market position and inflating prices. The swift action has sent a chill down API manufacturers’ spines.
Copyright © 2016-2022 PharmaDJ .All Rights Reserved.   Suggestions and feedback: Support@PharmaDJ.com   Record/License No.:沪ICP备17054709号-1  
About PharmaDJ | Subscription | Contact Us | Copyright Statement